| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T703 |
19-264 |
Sentence |
denotes |
Phase I clinical trial in healthy adult Biological: recombinant novel coronavirus vaccine (adenovirus type 5 vector) – 108, all, 18–60 Prevention Experimental: low‐dose group subjects received one dose of 5E10 vp Ad5‐nCoV at 18–60 years old |
| T704 |
265-296 |
Sentence |
denotes |
Experimental: middle‐dose group |
| T705 |
297-362 |
Sentence |
denotes |
Subjects received one dose of 1E11 vp Ad5‐nCoV at 18–60 years old |
| T706 |
363-392 |
Sentence |
denotes |
Experimental: high‐dose group |
